News Quantified

MDGL – madrigal pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Madrigal Pharmaceuticals (NASDAQ:MDGL) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.

Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..

Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "buy" rating reaffirmed by analysts at Cowen Inc.

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Volatility And Long Term Momentum [Yahoo! Finance]

Madrigal Pharmaceuticals (MDGL) Is Down 13.4% After Pfizer MASH Deal And Wolfe Downgrade - What's Changed [Yahoo! Finance]

3.4%

MISS

-2.6%

BEAT

-6.1%

BEAT

6.6%

BEAT

Form SCHEDULE 13D/A Canticle Pharmaceuticals Filed by: Taub Rebecca

Form SCHEDULE 13D/A Canticle Pharmaceuticals Filed by: FRIEDMAN PAUL A

Top News Gainers

10/27 Hedge Funds Are Dumping Madrigal Pharmaceuticals, Inc. (MDGL) [Yahoo! Finance News] 8.1%

11/8 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 7.3%

3/4 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.1%

4/17 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%

11/7 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) had its price target lowered by analysts at HC Wainwright from $225.00 to $215.00. They now have a "buy" rating on the stock. 5.0%

12/2 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $166.00 price target on the stock, down previously from $173.00. 3.6%

4/3 Intercept Pharmaceuticals: Your Transformative Year [Seeking Alpha] 3.5%

6/4 Madrigal Pharmaceuticals to Present at Upcoming Investment Conferences 3.2%

5/15 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $186.00 price target on the stock, down previously from $200.00. 3.2%

8/12 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was given a new $134.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 3.1%

Top News Decliners

12/10 Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock -16.4%

7/25 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -10.0%

4/28 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.9%

1/30 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) is now covered by analysts at Canaccord Genuity. They set a "buy" rating and a $198.00 price target on the stock. -6.6%

12/18 Madrigal Pharmaceuticals Announces First Patient Dosed in MAESTRO-NAFLD-1, a Second Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Resmetirom (MGL-3196) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Presumed NASH ( -5.7%

9/25 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -5.5%

11/14 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -4.9%

11/6 Q3/2019 9/30/2019 EPS -1.390 ZacksConsensus -1.360 ActVsEst (0.030) - Miss -4.6%

4/14 Madrigal Pharma up 13% on positive data on NASH drug resmetirom [Seeking Alpha] -3.8%

10/29 Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -3.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day